Kumar S, Hazlett K, Bai G. Mucosal immunity elicited by a human-Fcgamma receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens. Vaccine 2025;48:126729.
PMID: 39823848